BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9816300)

  • 1. Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study.
    McGinn CJ; Kunugi KA; Tutsch KD; Feierabend C; Alberti D; Lindstrom MJ; Wilding G; Arzoomanian RZ; Kinsella TJ
    Clin Cancer Res; 1996 Aug; 2(8):1299-305. PubMed ID: 9816300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.
    Morgan RJ; Newman EM; Doroshow JH; McGonigle K; Margolin K; Raschko J; Chow W; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Carroll M; Vasilev S; Akman S; Coluzzi P; Wagman L; Longmate J; Paz B; Yen Y; Klevecz R
    Cancer Res; 1998 Jul; 58(13):2793-800. PubMed ID: 9661893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study.
    Speth PA; Kinsella TJ; Belanger K; Klecker RW; Smith R; Rowland JB; Collins JM
    Cancer Res; 1988 May; 48(10):2933-7. PubMed ID: 2965970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I clinical and pharmacological study of iododeoxyuridine and bleomycin in patients with advanced cancer.
    Schilsky RL; Janisch L; Berezin F; Mick R; Vogelzang NJ; Ratain MJ
    Cancer Res; 1993 Mar; 53(6):1293-6. PubMed ID: 7680282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts.
    Kinsella TJ; Glennon MC; Kunugi KA; Lindstrom MJ
    Clin Cancer Res; 1996 Jun; 2(6):981-9. PubMed ID: 9816259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
    Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD
    Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of leucovorin on idoxuridine cytotoxicity and DNA incorporation.
    Greene RF; Collins JM
    Cancer Res; 1990 Oct; 50(20):6652-6. PubMed ID: 2208128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of hydroxyurea and iododeoxyuridine on the radiosensitivity of human bladder cancer cells.
    Kuo ML; Kunugi KA; Lindstrom MJ; Kinsella TJ
    Cancer Res; 1995 Jul; 55(13):2800-5. PubMed ID: 7796406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5'-aminothymidine and leucovorin on radiosensitization by iododeoxyuridine in human colon cancer cells.
    Miller EM; Kunugi KA; Kinsella TJ
    Clin Cancer Res; 1995 Apr; 1(4):407-16. PubMed ID: 9815998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine.
    Cook JA; Glass J; Lebovics R; Bobo H; Pass H; DeLaney TF; Oldfield EH; Mitchell JB; Glatstein E; Goffman TE
    Cancer Res; 1992 Feb; 52(3):719-25. PubMed ID: 1732059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo.
    Rodriguez R; Ritter MA; Fowler JF; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):105-13. PubMed ID: 8175417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study.
    Schulz CA; Mehta MP; Badie B; McGinn CJ; Robins HI; Hayes L; Chappell R; Volkman J; Binger K; Arzoomanian R; Simon K; Alberti D; Feierabend C; Tutsch KD; Kunugi KA; Wilding G; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1107-15. PubMed ID: 15234045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization.
    Taverna P; Hwang HS; Schupp JE; Radivoyevitch T; Session NN; Reddy G; Zarling DA; Kinsella TJ
    Cancer Res; 2003 Feb; 63(4):838-46. PubMed ID: 12591735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of iododeoxyuridine into DNA of granulocytes in patients.
    Belanger K; Klecker RW; Rowland J; Kinsella TJ; Collins JM
    Cancer Res; 1986 Dec; 46(12 Pt 1):6509-12. PubMed ID: 3779659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme.
    Kinsella TJ; Collins J; Rowland J; Klecker R; Wright D; Katz D; Steinberg SM; Glastein E
    J Clin Oncol; 1988 May; 6(5):871-9. PubMed ID: 2835444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of iododeoxyuridine-mediated radiosensitization by 5-fluorouracil in human colon cancer cells.
    Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
    Int J Radiat Oncol Biol Phys; 1992; 22(3):499-503. PubMed ID: 1735687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive interactive radiosensitisation in vitro with the combination of two nucleoside analogues, (E)-2'-deoxy-2'-(fluoromethylene) cytidine and iododeoxyuridine.
    Coucke PA; Cottin E; Azria D; Martineau P; Adamer F; Decosterd LA; Buchegger F; Do HP
    Eur J Cancer; 2004 Jul; 40(10):1572-80. PubMed ID: 15196542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low pH does not affect the dose response for 5'-amino-5'-deoxythymidine modulation of IdUrd DNA incorporation and radiosensitization in a human bladder cancer cell line.
    Kunugi KA; Miller EM; Vazquez-Padua MA; Kinsella TJ
    Radiat Res; 1992 Nov; 132(2):222-7. PubMed ID: 1438704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of IdUrd-DNA incorporation and radiosensitization in human bladder carcinoma cells.
    Kunugi KA; Vazquez-Padua MA; Miller EM; Kinsella TJ
    Cancer Res; 1990 Aug; 50(16):4962-7. PubMed ID: 2199032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.